Bionx launches bioresorbable implant:
This article was originally published in Clinica
Bionx Implants has launched its 4.5mm cannulated SmartScrew system. The product is a bioresorbable implant for maintaining alignment of cancellous bone fractures of the malleoulus of the ankle. The company believes there are 130,000 ankle fractures annually in the US that could be treated with resorbable fracture fixation. Blue Bell, Pennsylvania-based Bionx develops and manufactures self-reinforced, resorbable polymer implants for use in orthopaedic and craniofacial surgery as well as urological applications.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.